Aspire Private Capital, LLC Gilead Sciences, Inc. Transaction History

Aspire Private Capital, LLC

$385 Million
Q2 2024

A detailed history of Aspire Private Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aspire Private Capital, LLC holds 654 shares of GILD stock, worth $54,680. This represents 0.01% of its overall portfolio holdings.

Number of Shares

654

Previous 521 25.53%

Holding current value

$54,680

Previous $38,000 15.79%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$63.15 - $72.88 $8,398 - $9,693	133 Added 25.53%	654 $44,000
Q1 2024 Apr 18, 2024	BUY	$71.58 - $87.29 $2,648 - $3,229	37 Added 7.64%	521 $38,000
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $5,128 - $5,816	-70 Reduced 12.64%	484 $39,000
Q3 2023 Nov 03, 2023	SELL	$73.94 - $80.67 $517 - $564	-7 Reduced 1.25%	554 $41,000
Q2 2023 Jul 24, 2023	SELL	$76.01 - $86.7 $10,337 - $11,791	-136 Reduced 19.51%	561 $43,000
Q1 2023 May 30, 2023	SELL	$77.31 - $88.08 $9,586 - $10,921	-124 Reduced 15.1%	697 $57,000
Q1 2023 May 03, 2023	SELL	$77.31 - $88.08 $9,586 - $10,921	-124 Reduced 15.1%	697 $57,000
Q4 2022 May 30, 2023	BUY	$62.32 - $89.47 $7,727 - $11,094	124 Added 17.79%	821 $70,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $3,240 - $4,652	-52 Reduced 5.96%	821 $70,000
Q3 2022 Nov 10, 2022	SELL	$59.54 - $68.01 $4,584 - $5,236	-77 Reduced 8.11%	873 $54,000
Q2 2022 Aug 01, 2022	SELL	$57.72 - $65.01 $1,385 - $1,560	-24 Reduced 2.46%	950 $59,000
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $21,140 - $26,491	-365 Reduced 27.26%	974 $58,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $14,792 - $16,789	-228 Reduced 14.55%	1,339 $97,000
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $17,802 - $19,206	-263 Reduced 14.37%	1,567 $109,000
Q2 2021 Aug 09, 2021	SELL	$63.47 - $69.35 $176,637 - $193,001	-2,783 Reduced 60.33%	1,830 $126,000
Q1 2021 May 26, 2021	SELL	$60.0 - $68.46 $229,080 - $261,380	-3,818 Reduced 45.29%	4,613 $298,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $89,620 - $102,118	1,582 Added 23.1%	8,431 $491,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $271,811 - $341,756	4,377 Added 177.06%	6,849 $433,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $356,057 - $413,448	-4,922 Reduced 66.57%	2,472 $190,000
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $35,699 - $45,725	570 Added 8.35%	7,394 $553,000
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $9,612 - $10,573	-156 Reduced 2.23%	6,824 $443,000
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $425,005 - $469,131	6,799 Added 3756.35%	6,980 $442,000
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $3,279 - $3,677	53 Added 41.41%	181 $12,000
Q4 2018 Feb 25, 2019	BUY	$60.54 - $79.0 $6,962 - $9,085	115 Added 884.62%	128 $8,000
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $787 - $1,027	13 New	13 $8,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.

Account

Aspire Private Capital, LLC Gilead Sciences, Inc. Transaction History